Nuclear tristetraprolin acts as a corepressor of multiple steroid nuclear receptors in breast cancer cells
Tristetraprolin (TTP) is a 34-kDa, zinc finger-containing factor that in mammalian cells acts as a tumor suppressor protein through two different mechanisms. In the cytoplasm TTP promotes the decay of hundreds of mRNAs encoding cell factors involved in inflammation, tissue invasion, and metastasis....
Main Authors: | Tonatiuh Barrios-García, Vania Gómez-Romero, Ángeles Tecalco-Cruz, Viviana Valadéz-Graham, Alfonso León-Del-Río |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-06-01
|
Series: | Molecular Genetics and Metabolism Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221442691630009X |
Similar Items
-
Sources, Pollution Characteristics, and Ecological Risk Assessment of Steroids in Beihai Bay, Guangxi
by: Chaoxing Ren, et al.
Published: (2022-04-01) -
Nuclear Receptor CoRepressors, NCOR1 and SMRT, are required for maintaining systemic metabolic homeostasis
by: Megan J. Ritter, et al.
Published: (2021-11-01) -
Nuclear receptor corepressor 1 represses cardiac hypertrophy
by: Chao Li, et al.
Published: (2019-11-01) -
FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
by: Darcie D. Seachrist, et al.
Published: (2021-10-01) -
The functional characterization of phosphorylation of tristetraprolin at C-terminal NOT1-binding domain
by: Hsin-Hui Hsieh, et al.
Published: (2021-06-01)